Introduction: Digital health solutions are advancing rapidly in the field of diagnostics, emergency response, hospital management. As the goal of individuals shifts more...
- 1
- 2
- 3
- 4
The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is an organization dedicated to providing its members with opportunities to enhance their professional development and maximize career opportunities. Whether you are a student, an entry-level associate or an experienced executive, a membership with CAPRA is a must.
We foster learning, networking and professional excellence of our members. We will build and strengthen relationships with governmental agencies, scientific experts and industry educators in order to create an affordable, professionally fulfilling and academically enriching environment for our members.
Introduction to Regulatory Affairs and the Regulatory Affairs Profession
LEARN MOREReach CAPRA members through the NOC (News of Course), or place an employment ad in our listings.
LEARN MOREAvailable to CAPRA Members
Planning to place an employment advertisement through CAPRA/ACRP? Looking for a new career opportunity? If so, you have come to the right place! CAPRA now has over 900 members in the regulatory affairs field!
Job Seekers: Scroll through our most recent postings, your dream job maybe at your fingers tips!
Employers: Regulatory professionals are difficult to find. Win the competition for talent, by advertising in CAPRA. Our email employment notice service brings you access to hundreds of top class, experienced professionals. One of them may be just whom you are looking for!
VIEW OPPORTUNITIESIntroduction: Digital health solutions are advancing rapidly in the field of diagnostics, emergency response, hospital management. As the goal of individuals shifts more...
What are Rare Diseases and How do They Affect Canadians? According to Health Canada, rare diseases are life-threatening, debilitating, or serious and chronic conditions that...
Did you know, effective immediately, Health Canada is changing the submission requirements for second language product monographs for human drugs? This is for only post-life...